Northrop Grumman (NOC) Stock Forecast & Price Target

Northrop Grumman is attractive fundamentally because its portfolio is anchored by long-duration national security programs, especially B-21 and Sentinel, which are shifting from development to production and should support a durable revenue floor through the FYDP and beyond. Management’s 2026 guidance for about 5% organic sales growth and 11.3% segment margins, combined with Defense Systems, space, hypersonics, autonomy, and international expansion, gives it multiple growth levers even if its 2028 CAGRs trail peers. The investment case is strengthened by rising backlog, a nearly $35 billion Defense Systems backlog, and the expectation that margin upside will increasingly come from better mix, production scale, and higher-margin international work rather than pure expansion.

Northrop Grumman is viewed negatively because its growth outlook appears merely in line with peers, with ~6% top-line growth through 2028 depending on incremental investment in B-21, space, and SRM programs rather than clear organic upside. Margin expansion is also constrained by the B-21’s fixed-price LRIP losses, lingering execution and production-mix risks, Sentinel restructuring overhang, and lower legacy-program volume, while the new executive order restricting capital deployment removes a key support to EPS and FCF. With 2028 free cash flow estimated at $3.5B–$3.6B and valuation cut to 21x from 25.6x, the analyst sees little justification for a premium multiple as defense-spending sentiment and budget growth concerns weigh on the stock.